Literature DB >> 7813561

Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression.

P S D'Aquila1, M Collu, L Pani, G L Gessa, G Serra.   

Abstract

We compared the effect of two selective dopamine D1 receptor agonists, SKF 38393 ((+/-)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol.HCl) and A68930 ((1R,3S)-1-aminomethyl-5,6-dihydroxy-3-phenylisochroman.HCl), and that of imipramine in the behavioural despair model of depression. The dopamine D1 receptor agonists and imipramine showed an anti-immobility effect. Moreover we found that the 'antidepressant' effect of imipramine in the behavioural despair test was antagonized by SCH 23390, a selective dopamine D1 receptor blocker. The results further support the hypothesis that dopamine D1 receptor stimulation plays an important role in the mechanism of action of antidepressants and suggest that dopamine D1 receptor agonists might be considered as potential antidepressant drugs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813561     DOI: 10.1016/0014-2999(94)90033-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Chronic fluoxetine selectively upregulates dopamine D₁-like receptors in the hippocampus.

Authors:  Katsunori Kobayashi; Eisuke Haneda; Makoto Higuchi; Tetsuya Suhara; Hidenori Suzuki
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

2.  A new strategy for antidepressant prescription.

Authors:  Francis Lavergne; Thérèse M Jay
Journal:  Front Neurosci       Date:  2010-11-19       Impact factor: 4.677

3.  Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats.

Authors:  Kouhei Kitagawa; Yoshihisa Kitamura; Toshiaki Miyazaki; Junya Miyaoka; Hiromu Kawasaki; Masato Asanuma; Toshiaki Sendo; Yutaka Gomita
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-10       Impact factor: 3.000

4.  Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.

Authors:  Hideki Taoka; Takashi Hamamura; Shiro Endo; Shinji Miyata; Kishio Toma; Takeshi Ishihara; Shigetoshi Kuroda
Journal:  Psychopharmacology (Berl)       Date:  2008-09-06       Impact factor: 4.530

5.  Strain differences in the expression of dopamine D1 receptors in Wistar-Kyoto (WKY) and Wistar rats.

Authors:  Andrew Novick; Irene Yaroslavsky; Shanaz Tejani-Butt
Journal:  Life Sci       Date:  2008-05-24       Impact factor: 5.037

6.  Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.

Authors:  Tina Scardochio; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

7.  Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats.

Authors:  Kimberly R Tyeryar; Ashiwel S Undie
Journal:  Psychopharmacology (Berl)       Date:  2007-04-15       Impact factor: 4.415

8.  Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety.

Authors:  Joana E Coelho; Pedro Alves; Paula M Canas; Jorge S Valadas; Tatiana Shmidt; Vânia L Batalha; Diana G Ferreira; Joaquim A Ribeiro; Michael Bader; Rodrigo A Cunha; Frederico Simões do Couto; Luísa V Lopes
Journal:  Front Psychiatry       Date:  2014-06-13       Impact factor: 4.157

9.  Maternal deprivation enhances behavioral vulnerability to stress associated with miR-504 expression in nucleus accumbens of rats.

Authors:  Yi Zhang; Xiongzhao Zhu; Mei Bai; Li Zhang; Liang Xue; Jinyao Yi
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain.

Authors:  Kimberly R Tyeryar; Habiba O U Vongtau; Ashiwel S Undieh
Journal:  BMC Neurosci       Date:  2008-01-24       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.